Quoting from the CID4 Blog posting by Adam Rubenstein about the recent Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC):
"The success metric for an investor and partnering conference is unambiguous, a company must achieve either an initial inquiry of interest or secure a follow-on meeting. Using such a performance metric illuminated a very satisfactory grade for the presenting CID4 portfolio companies. The Rocky Mountain Life Science Investor and Partnering Conference was more than simply a CID4 showcase, what transpired at the historic Brown Palace Hotel was the culmination of a biocluster clearly on the rise. Colorado had an important opportunity to spotlight their diverse array of high-impact technologies and high-quality intellectual capital, and put a stamp on the Rocky Mountain region as a bioscience node that demands the attention of industry and investors. A quick scan of attendees validates that the Front Range deal flow ranks on par with any other cluster across the U.S."
Link to the Colorado Institute for Drug, Device and Diagnostic Development (CID4) Blog posting